Global public health efforts to address HIV and related communicable disease syndemics.
Journal
Current opinion in HIV and AIDS
ISSN: 1746-6318
Titre abrégé: Curr Opin HIV AIDS
Pays: United States
ID NLM: 101264945
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
19
8
2021
Statut:
ppublish
Résumé
To review recent progress in public health efforts to address HIV, and the extent to which key approaches can be applied to three key epidemics that commonly co-occur with HIV: TB, viral hepatitis, and STIs. The public health approach to tackling HIV in low-income and middle-income settings relied on standardized treatment regimens and monitoring approaches, task sharing and community involvement, and decentralized and integrated service delivery. These approaches can all be applied to three key epidemics that commonly co-occur with HIV: TB, viral hepatitis, and STIs. HIV, viral hepatitis, and STIs share common routes of infection, and HIV weakens the immune system, increasing the risk of TB. A public health approach can be applied to address these syndemics.
Identifiants
pubmed: 32496325
doi: 10.1097/COH.0000000000000636
pii: 01222929-202007000-00009
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-265Références
Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505–510.
Ford N, Ball A, Baggaley R, et al. The WHO public health approach to HIV treatment and care: looking back and looking ahead. Lancet Infect Dis 2018; 18:e76–e86.
Singer M, Snipes C. Generations of suffering: experiences of a treatment program for substance abuse during pregnancy. J Healthcare Poor Underserved 1992; 3:222–234.
Singer M. Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease. Virulence 2010; 1:10–18.
Vitoria M, Hill A, Ford N, et al. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues? AIDS 2018; 32:1551–1561.
Vitoria M, Ford N, Clayden P, et al. When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank. Curr Opin HIV AIDS 2017; 12:414–422.
Penazzato M, Townsend CL, Rakhmanina N, et al. PADO4 participants. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list. Lancet HIV 2019; 6:e623–e631.
World Health Organization. Antitetroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva, 2006.
Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018; 379:979–981.
WHO: Updated recommendations on first-line and second-line antiretroviral regimens and postexposure prophylaxis and recommendations on early infant diagnosis of HIV Interim guidance. Geneva. 2018.
Zash R, Holmes L, Diseko M, et al. Neural-tube defects and antiretroviral treatment regimens in Botswana. N Engl J Med 2019; 381:827–840.
Mofenson LM, Pozniak AL, Wambui J, et al. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. J Int AIDS Soc 2019; 22:e25352.
World Health Organization. Update of recommendations on first- and second-line antiretroviral regimens. Geneva. 2019.
Ford N, Meintjes G, Vitoria M, et al. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS 2017; 12:123–128.
Ford N, Meintjes G, Calmy A, et al. Guideline development group for managing advanced HIV disease. Managing advanced HIV disease in a public health approach. Clin Infect Dis 2018; 66:S106–SS110.
WHO: consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach -- second edition. 2016.
Vojnov L, Taegtmeyer M, Boeke C, et al. Performance of nonlaboratory staff for diagnostic testing and specimen collection in HIV programs: a systematic review and meta-analysis. PLoS One 2019; 14:e0216277.
Labhardt ND, Ringera I, Lejone TI, et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE Randomized Clinical Trial. JAMA 2018; 319:1103–1112.
WHO. Health policy and system support to optimise community health worker programmes for HIV services: an implementation guide. Geneva. 2020.
Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev 2013; CD009987.
Low AJ, Mburu G, Welton NJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis 2016; 63:1094–1104.
Suthar AB, Rutherford GW, Horvath T, et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS 2014; 28: (Suppl 2): S175–S185.
Grimsrud A, Bygrave H, Doherty M, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc 2016; 19:21484.
Roy M, Bolton Moore C, Sikazwe I, Holmes CB. A review of differentiated service delivery for HIV treatment: effectiveness, mechanisms, targeting, and scale. Curr HIV/AIDS Rep 2019; 16:324–334.
WHO. Global tuberculosis report. Geneva. 2019.
WHO. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva. 2017.
WHO. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV. Policy update (2019). Geneva. 2019.
WHO. Consolidated guidelines on HIV testing services for a changing epidemic. Geneva. 2019.
Hamada Y, Lujan J, Schenkel K, et al. Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. Lancet HIV 2018; 5:e515–e523.
WHO policy on collaborative TB/HIV activities. guidelines for national programmes and other stakeholders. Geneva. 2012.
Weyer K, Falzon D, Jaramillo E. Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis. Bull World Health Organ 2018; 96:667–1667.
WHO. Consolidated guidelines on drug-resistant tuberculosis treatment. Geneva. 2019.
WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva. 2019.
Platt L, French CE, McGowan CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat 2020; 27:294–315.
WHO. Global Hepatitis Report. 2017.
Platt L, French CE, McGowan CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepat 2019; 27:294–315.
Platt L, Easterbrook P, Gower E, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis 2016; 16:797–808.
WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva. 2015.
WHO. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva. 2018.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3–17.
Mayer K, Venkatesh K. Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition. Am J Reprod Immunol 2011; 65:308–316.
Ong JJ, Baggaley RC, Wi TE, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open 2019; 2:e1917134.
WHO, PrEP implementation tool (2017). Available at: http://www.who.int/hiv/pub/prep/prep-implementation-tool/en/.
Toskin I, Peeling RW, Mabey D, et al. Point-of-care tests for STIs: the way forward. Sex Transm Infect 2017; 93:S1–S2.
Wi T, Ndowa F, Ferreyra C, et al. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward. J Intern AIDS Society 2019; 22: (Suppl 6): e25343.